During a live event, Praneeth Baratam, MBBS, discussed the molecular factors that affect staging of lower-risk myelodysplastic syndromes.

A study suggests that lupus-like manifestations in patients with MDS/CMML frequently reflect clonal myeloid infiltration.

Myelodysplastic syndromes (MDS) are treated based on type and risk assessment, but traditional therapies may not work for everyone. Clinical trials offer a way to explore emerging treatments and ...

April 30, 2010 — Myelodysplastic syndromes (MDS) appear to be nearly 5 times more common in older adults than previously thought, according to a new study published online April 26 in the Journal of ...

Learn how MDS/CMML-associated lupus differs from classic lupus and why clone-directed therapies may offer better outcomes.

More and more hematology factors and parameters can be analyzed with advanced equipment to better pinpoint which patients might have myelodysplastic syndromes (MDS)—but the differences in leading ...

The study is among the first to look at the potential impacts of clonal dynamics on patients with lower-risk myelodysplastic syndromes (MDS). However, most of what scientists know about the impact of ...

MPNs involve overproduction of blood cells, while MDS results in poorly formed cells, affecting blood cell function and counts. Diagnosis requires blood tests, bone marrow biopsy, and genetic testing ...

Researchers suggest that this dataset could significantly accelerate innovation in AI-based diagnostics for blood disorders.

It's called myelodysplastic syndrome, or MDS. It's a blood and bone marrow disease, linked to the cancer treatment that once saved her life. The 51-year-old broke the news on Monday morning's show ...